New Novo Nordisk drug could beat market leaders for weight loss, early results show

  • Posted on June 20, 2025
  • By Financial Times
  • 3 Views
New Novo Nordisk drug could beat market leaders for weight loss, early results show

Participants in trial of amycretin injectable obesity drug lost an average of 24% of their body weight on highest dose
continue reading...

Author
Financial Times

You May Also Like